SEC Form 4 · accession 0001179110-16-025259
Assertio Therapeutics, Inc · ASRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter D Staple
Director
Period of report
May 18, 2016
Accepted (ET)
May 20, 2016 · 7:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005201
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1,F2 | $19.16 | May 18, 2016 | A | 7,669 | A | — | May 18, 2026 | Common Stock | 7,669 | 7,669 | D |
| Restricted Stock UnitsF1,F3,F4 | — | May 18, 2016 | A | 3,131 | A | — | — | Common Stock | 3,131 | 3,131 | D |
Explanation of responses
- F1Automatic grant of stock options and restricted stock unit awards pursuant to the Company's Non-Employee Director Compensation and Grant Policy.
- F2Exercisable in twelve equal monthly installments.
- F3Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
- F4These restricted stock units are scheduled to vest on May 18, 2017, assuming continued service through the applicable vesting date.